Associated Papers
Intrinsic resistance to RAS inhibitors is driven by dysregulation of KRAS degradation.
Ivanisevic T et al.
Nature Communications, 2025
RAF1 contributes to cell proliferation and STAT3 activation in colorectal cancer independently of microsatellite and KRAS status.
Dorard C et al.
Oncogene, 2023
37020037 (PubMed )
Supplement: 41388_2023_2683_MOESM1_ESM.pdf
Combination of ATP-competitive mammalian target of rapamycin inhibitors with standard chemotherapy for colorectal cancer.
Atreya CE et al.
Investigational New Drugs, 2012
Novel Cdc42-binding proteins Gic1 and Gic2 control cell polarity in yeast.
Brown JL et al.
Genes & Development, 1997
Select a paper to view details